Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis

Julien CALDERARO, JC Nault, C Balabaud, G Couchy, MC Saint-Paul, D Azoulay, D Mehdaoui, Alain LUCIANI, ES Zafrani, P Bioulac-Sage, J Zucman-Rossi,

Mod Pathol 01/01/2016;29(1) : 43-50 10.1038/modpathol.2015.119. 30/10/2015

Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.

C Sempoux, V Paradis, M Komuta, Julien CALDERARO, C Balabaud, A Quaglia, P Bioulac-Sage,

J Hepatol 01/11/2015;63(5) : 1173-1180 10.1016/j.jhep.2015.06.017. 25/06/2015

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.

JC Nault, S Datta, S Imbeaud, A Franconi, A Mallat, G Couchy, E Letouze, C Pilati, B Verret, JF Blanc, C Balabaud, Julien CALDERARO, A Laurent, M Letexier, P Bioulac-Sage, F Calvo, J Zucman-Rossi,

Nat Genet 01/10/2015;47(10) : 1187-1193 10.1038/ng.3389 24/08/2015

BRAF V600E mutational status in bile duct adenomas and hamartomas.

A Pujals, P Bioulac-Sage, C Castain, C Charpy, ES Zafrani, Julien CALDERARO,

Histopathology 01/10/2015;67(4) : 562-7 10.1111/his.12674. 31/03/2015

Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

C Lim, P Compagnon, M Sebagh, C Salloum, Julien CALDERARO, Alain LUCIANI, G Pascal, A Laurent, E Levesque, U Maggi, Cyrille FERAY, D Cherqui, D Castaing, D Azoulay,

HPB (Oxford) 01/07/2015;17(7) : 611-623 10.1111/hpb.12416 16/05/2015

Bile duct adenoma should not be designated as a reactive process.

A Pujals, ES Zafrani, Julien CALDERARO,

Pathol Int 01/06/2015;65(6) : 338 10.1111/pin.12273. 02/03/2015

Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas

Giuliana AMADDEO, Q Cao, Y Ladeiro, S Imbeaud, JC Nault, D Jaoui, Y Gaston Mathe, C Laurent, A Laurent, P Bioulac-Sage, Julien CALDERARO, J Zucman-Rossi,

Gut. 01/05/2015;64(5) : 820-829 10.1136/gutjnl-2013-306228. 09/06/2014

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

K Schulze, S Imbeaud, E Letouze, LB Alexandrov, Julien CALDERARO, S Rebouissou, G Couchy, C Meiller, J Shinde, F Soysouvanh, R Pinyol, L Pelletier, C Balabaud, A Laurent, JF Blanc, V Mazzaferro, F Calvo, A Villanueva, JC Nault, P Bioulac-Sage, MR Stratton, JM Llovet, J Zucman-Rossi,

Nat Genet 01/05/2015;47(5) : 505-511 10.1038/ng.3252 30/03/2015

Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.

X Li, J Tao, A Cigliano, M Sini, Julien CALDERARO, D Azoulay, C Wang, Y Liu, L Jiang, K Evert, MI Demartis, S Ribback, K Utpatel, F Dombrowski, M Evert, DF Calvisi, X Chen,

Oncotarget 30/04/2015;6(12) : 10102-15 .

BRAF V600E mutations in bile duct adenomas

A Pujals, Giuliana AMADDEO, C Castain, P Bioulac-Sage, P Compagnon, J Zucman-Rossi, D Azoulay, V Leroy, ES Zafrani, Julien CALDERARO,

Hepatology. 01/01/2015;61(1) : 403-405 10.1002/hep.27133 19/05/2014